| Diagnostic molecular imaging technology |
WP 1 | Ultra-high resolution cerebral and heart imaging and quantitation with single-photon emitters |
WP 2 | Quantitative microPET and multi-modality (PET/MR, OT/MR) scanner development |
| |
| Library of diagnostic molecular imaging probes |
WP 3 | Development of radioparmaceutical probes for neurodegenerative diseases |
WP 4.1 | Development of library of innovative MRI probes and improved methodes for "in vivo"cellular labelling |
WP 4.2 | Development of optical and combined imaging probes |
| |
| Library of animal models |
WP 5 | Animal library for diagnostic molecular imaging in neuroscience and cardiovascular |
WP 6 | Evaluation of the role of estrogen and estrogen receptors in a mouse model of Alzheimer disease and generation of novel report systems |
| |
| Neuroscience |
WP 7 | Non-invasive phenotyping of animal models for neurodegenerative diseases |
WP 8.1 | Identification of novel neuroimaging targets in neurodegenerative disease (merged into WP8.2) |
WP 8.2 | Early diagnosis of neurodegenerative disease |
WP 9 | Neuroinflammation |
WP 10 | Stem cell trafficking in the CNS |
| |
| Cardiovascular science
|
WP 11.1 | Multimodality charcacterization of atherosclerotic plaques |
WP 11.2 | Characterization of myocardial angiogenesis |
WP 12 | Cardiac stem cell therapy monitored by molecular imaging |
| |
| Inflammation & regeneration |
WP 10 | see topic 2.1 |
WP 12 | see topic 2.2 |
WP 13 | Molecular imaging of NF-κB activation and imaging chronic inflammation using optical probes |
| |
| Integration, training, dissemination |
WP 14 | Integration activities |
WP15.1 | Activities of the Board for Training (BOT) |
WP15.2 | Activities of the Board for Dissemination and Communication (BODIC) |
| |
| Management |
WP 16 | Management activities |